Learn More
Medchemexpress LLC Tbopp | 1996629-79-8 | 99.6% | 490.49 g·mol⁻¹ | C24H21F3N2O4S | 5MG

Supplier: Medchemexpress LLC HY1247115MG
TBOPP is a selective small-molecule inhibitor of DOCK1 that binds the DOCK1 DHR-2 domain and inhibits DOCK1-mediated Rac activation. It is used in preclinical research to probe DOCK1 signaling and evaluate anti-tumor effects in cell and animal studies.
- Selective DOCK1 inhibitor with IC50 8.4 μM.
- High-affinity binding to the DHR-2 domain (Kd 7.1 μM).
- Molecular formula C24H21F3N2O4S; molecular weight 490.49 g·mol⁻¹.
- High purity (99.55%).
- Soluble in DMSO (100 mg/mL) and compatible with common in vivo formulations.
- Powder stable at -20°C for extended storage.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.